Reyoung Pharmaceuticals is an API manufacturer based in Nigeria. It holds 9 active US drug master files across a filed portfolio of 9 molecules. Its filings concentrate with FDA (GH), US FDA and UZPHARM (UZ). Its GMP standing is certified by FDA (GH) and NAFDAC (NG).
| Site | FDA FEI |
|---|---|
| Shandong Province, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Aripiprazole | US FDA | 1 |
| Avanafil | US FDA | 1 |
| Avatrombopag | US FDA | 1 |
| Azilsartan Medoxomil | US FDA | 1 |
| Dapoxetine | US FDA | 1 |
| Moxifloxacin | US FDA | 1 |
| Rilpivirine | US FDA | 1 |
| Tenofovir Alafenamide | US FDA | 1 |
| Topiroxostat | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| FDA (GH) | 44 | 1 |
| US FDA | 8 | None |
| UZPHARM (UZ) | 3 | None |
| ARCSA (EC) | 1 | None |
| NAFDAC (NG) | None | 1 |
Choose your molecules and target markets. Reyoung Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free